Keywords: ec, approves, expanded, indication, velcade, health, care

EC approves expanded indication for Velcade

Article | 15 September 2008

Print This

US health care major Johnson & Johnson's multiple myeloma drug Velcade (bortezomib) has been approved by the European Commission for use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in